Skip to main content
See every side of every news story
Published loading...Updated

Kazia Therapeutics Limited Announces Proposed Public Offering

Kazia said proceeds will fund paxalisib studies in breast cancer and other oncology indications, while Series A and B warrants hinge on future trial readouts.

Summary by The AI Journal
Open the article to view the coverage from The AI Journal

6 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in Chicago, United States on Thursday, August 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal